Zimmer weakness creates buying opportunity, says RBC Capital RBC Capital believes that Zimmer reported strong Q4 results, and the firm thinks the company's Q1 guidance is conservative. The firm believes that the stock is undervalued at current levels and keeps an Outperform rating on the shares.
BIOLASE CEO Jeffrey Nugent to step down, Harold Flynn appointed CEO BIOLASE (BIOL) announced that Harold Flynn Jr. will become president and CEO, effective July 13. The current president and CEO Jeffrey Nugent will step down at that time. Since 2007, Flynn has been president of Zimmer Dental, a manufacturer and provider of medical devices for the dental market. Zimmer Dental is a division of Zimmer Holdings (ZMH).